NIFEDIPINE MEDICATION MARKET ANALYSIS

Nifedipine Medication Market, By Dosage Form (Tablets, Extended-release Tablets, Capsules, and Others (Sublingual tablets/spray, Patches and Others)), By Indication (Hypertension, Angina Pectoris, Raynaud\\\'s Phenomenon, and Others (Pre-term labor, vasospastic conditions and Others)), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI5938
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East

North America is expected to dominate the market during the forecast period, which accounted for a share of 37.2% in 2022 This is due to the increasing prevalence of chronic diseases such as heart failure, arrhythmias, and hypertension in the region.

Europe is expected to be the second-largest market for nifedipine medication, which accounted for a share of 28.5% in 2022. This is due to the rising awareness about the benefits of nifedipine and the increasing healthcare expenditure in the region.

Asia Pacific is expected to be the fastest-growing market for nifedipine medication, registering a CAGR of 9.2% during the forecast period. This is due to the increasing prevalence of chronic diseases such as heart failure, arrhythmias, and hypertension in the region, along with the rising healthcare expenditure.

NIFEDIPINE MEDICATION MARKET ANALYSIS

Regional Analysis

Nifedipine Medication Market Report Snapshots

EXISTING CLIENTELE